Skip to Navigation | Skip to Main Content | Skip to Site Map

MyFloridaHouse.gov | Mobile Site

Senate Tracker: Sign Up | Login

The Florida Senate

HB 885: Prescription Drugs Used in the Treatment of Schizophrenia for Medicaid Recipients

GENERAL BILL by McFarland ; (CO-INTRODUCERS) Caruso ; Eskamani ; Hunschofsky ; Joseph

Prescription Drugs Used in the Treatment of Schizophrenia for Medicaid Recipients; Authorizes approval of drug products or certain medication prescribed for treatment of schizophrenia or schizotypal or delusional disorders for Medicaid recipients who have not met step-therapy prior authorization criteria under certain circumstances.

Effective Date: 7/1/2022
Last Action: 3/3/2022 House - Laid on Table; companion bill(s) passed, see SB 534 (Ch. 2022-27)
Bill Text: PDF



Bill History

Date Chamber Action
12/9/2021 House • Filed
1/3/2022 House • Referred to Finance & Facilities Subcommittee
• Referred to Health Care Appropriations Subcommittee
• Referred to Health & Human Services Committee
• Now in Finance & Facilities Subcommittee
1/11/2022 House • 1st Reading (Original Filed Version)
2/4/2022 House • Added to Finance & Facilities Subcommittee agenda
2/8/2022 House • Favorable by Finance & Facilities Subcommittee
• Reported out of Finance & Facilities Subcommittee
• Now in Health Care Appropriations Subcommittee
2/10/2022 House • Added to Health Care Appropriations Subcommittee agenda
2/14/2022 House • Favorable by Health Care Appropriations Subcommittee
• Reported out of Health Care Appropriations Subcommittee
• Now in Health & Human Services Committee
2/21/2022 House • Added to Health & Human Services Committee agenda
2/23/2022 House • Favorable by Health & Human Services Committee
• Reported out of Health & Human Services Committee
• Bill released to House Calendar
• Added to Second Reading Calendar
2/28/2022 House • Bill added to Special Order Calendar (3/3/2022)
3/3/2022 House • Substituted SB 534
• Laid on Table; companion bill(s) passed, see SB 534 (Ch. 2022-27)